Insiders Trades
Arctic Bioscience AS Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 21 Oct 2024.
Arctic Bioscience AS: what insiders have been doing
Arctic Bioscience AS, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Oslo Børs. From 18 October 2025 to 18 October 2026, the disclosure feed for Arctic Bioscience AS logged 2 filings by 1 insider.
No insider bought on the market over the period, while 1 insider filed 1 sale. The amount is not disclosed for 1 filing.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 257 companies) published 4 filings over the same period, against 2 filings here. Looking back to 2021, when coverage begins, insiders filed 39 purchases and 9 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Insider Decl.
56
Thresholds
n/a
Buy Volume
€46M
39 ops. · all time
Sell Volume
€5M
9 ops. · all time
Who traded when
BuySaleBoard Member Per Magne1 sale
Christer L. Valderhaug1 sale
Since the insiders bought
- +75.4%Entry NOK 1.91 · Close at T+365 NOK 3.35
- +105.5%Entry NOK 1.65 · Close at T+365 NOK 3.39
- +105.5%Entry NOK 1.65 · Close at T+365 NOK 3.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 23,113 of 24,148 companies
14.8
score / 100
Value4
Quality26
FCF yld-61%
Earn yld-55%
EV/EBITDA·
ROE-23%
Gross mgn28%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NOK 2.76
Analyst consensus
Income statement
RevenueNOK 40.1M
Gross profitNOK 11M28% margin
EBITDA-NOK 26.8M-67% margin
Net income-NOK 41M-81.9% margin
Valuation
P/Book0.5x
Beta1.10
Balance sheet & cash
Market capNOK 74.4M
Total debtNOK 63.3M
Free Cash Flow-NOK 45.4M
Debt / Equity52%
Profitability & ownership
ROE-22.9%
ROA-6.8%
% insiders51.2%
% institutions1.4%
Last declaration on 1 April 2026
Declarations56 total
MERKOSLO:669931
MERKOSLO:669930
MERKOSLO:636419
MERKOSLO:636418
10,000 shares@ NOK 1.720.2% of flowShareMERKOSLO:630017
Canonical exit: 19 Jan 2025 (T+90)
10,000 sharesShareMERKOSLO:630016
Canonical exit: 19 Jan 2025 (T+90)
520,240 shares@ NOK 2.23100.0% of flowShareMERKOSLO:629927
520,240 sharesShareMERKOSLO:629926
2,000 sharesShareMERKOSLO:629908
Canonical exit: 16 Jan 2025 (T+90)
2,000 shares@ NOK 2.400.9% of flowShareMERKOSLO:629907
Canonical exit: 16 Jan 2025 (T+90)
20,000 sharesShareMERKOSLO:629884
Canonical exit: 16 Jan 2025 (T+90)
20,000 shares@ NOK 2.32100.0% of flowShareMERKOSLO:629883
Canonical exit: 16 Jan 2025 (T+90)
5,000 shares@ NOK 2.50100.0% of flowShareMERKOSLO:629781
Canonical exit: 15 Jan 2025 (T+90)
5,000 sharesShareMERKOSLO:629780
Canonical exit: 15 Jan 2025 (T+90)
10,000 shares@ NOK 2.869.0% of flowShareMERKOSLO:629721
Canonical exit: 14 Jan 2025 (T+90)
10,000 sharesShareMERKOSLO:629720
Canonical exit: 14 Jan 2025 (T+90)
5,000 shares@ NOK 3.0049.0% of flowShareMERKOSLO:629710
Canonical exit: 14 Jan 2025 (T+90)
5,000 sharesShareMERKOSLO:629709
Canonical exit: 14 Jan 2025 (T+90)
5,000 shares@ NOK 3.0850.6% of flowShareMERKOSLO:629675
Canonical exit: 13 Jan 2025 (T+90)
5,000 sharesShareMERKOSLO:629674
Canonical exit: 13 Jan 2025 (T+90)
ShareMERKOSLO:628242
3,087,999 shares@ NOK 13.50100.0% of flowShareMERKOSLO:628241
10 shares@ NOK 10.420.3% of flowShareMERKOSLO:624132
Canonical exit: 24 Oct 2024 (T+90)
10,000 sharesShareMERKOSLO:624131
Canonical exit: 24 Oct 2024 (T+90)
4 shares@ NOK 10.50100.0% of flowShareMERKOSLO:622957
Canonical exit: 30 Sept 2024 (T+90)
25 of 56 declarations
About Arctic Bioscience AS
Arctic Bioscience AS is a company focused on the health and pharmaceutical sector, dedicated to developing innovative solutions for human health. It is listed on the XOSL market.
